IL6 and COVID-19: The meta-analysis and regression published by Dhar et al. showed that out of the many cytokines elevated in COVID-19, IL-10 and IL-6 alone are sufficient to determine and predict the risk of the severe clinical course of the disease, allowing for early interventions which will result in better prognoses [36].